8th Joint Transnational Call of EuroNanoMed III

Under the umbrella of EuroNanoMed III, the 8th Joint Transnational Call will be launched for funding multilateral innovative research projects on nanomedicine together with the European Commission under the ERA-NET Cofund mechanism.
Submission deadline for pre-proposals: 16th January 2017
- Submission deadline of full proposals: 9th June 2017
- Available budget for this Call: EUR 14 Million (approx.)

TOPICS OF THE CALL
Project proposals will address multidisciplinary and translational research. Project proposals
will need to cover at least one of the following areas that are equal in relevance for this call:
a) Regenerative medicine
b) Diagnostics
c) Targeted delivery systems

The projects should fall within Technology Readiness Levels (TRL)1 3-6, although for being realistic and coherent with the characteristics of the call, projects should propose advancements for a maximum of two TRL levels during their lifetime.

GENERAL CONDITIONS FOR APPLICATION
A consortium applying to this call will be required to include research group(s) from at least two of the three following categories, if eligible according to relevant national/regional funding organisations’ regulations for research funding:

• Academia (research teams working in universities, other higher education institutions or research institutes);
• Clinical/public health sector (research teams working in hospitals/public health and/or other health care settings and health organisations). Participation of medical doctors is encouraged;
• Enterprise (all sizes of private companies). Participation of small and medium-size enterprises (SMEs) will be encouraged.

Only transnational projects will be funded. Each consortium submitting a proposal will need to involve a minimum of three eligible and a maximum of five eligible partners from at least three different countries participating to the call (see list below) though no more than two eligible partners from the same country participating in the call will be accepted in one consortium.

Further details:
http://www.euronanomed.net